Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat

HIV-1 integrates into the genome of target cells and establishes latency indefinitely. Understanding the molecular mechanism of HIV-1 latency maintenance is needed for therapeutic strategies to combat existing infection. In this study, we found an unexpected role for Apobec3A (apolipoprotein B MRNA...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 116; no. 6; pp. 2282 - 2289
Main Authors Taura, Manabu, Song, Eric, Ho, Ya-Chi, Iwasaki, Akiko
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 05.02.2019
SeriesPNAS Plus
Subjects
Online AccessGet full text
ISSN0027-8424
1091-6490
1091-6490
DOI10.1073/pnas.1819386116

Cover

More Information
Summary:HIV-1 integrates into the genome of target cells and establishes latency indefinitely. Understanding the molecular mechanism of HIV-1 latency maintenance is needed for therapeutic strategies to combat existing infection. In this study, we found an unexpected role for Apobec3A (apolipoprotein B MRNA editing enzyme catalytic subunit 3A, abbreviated “A3A”) in maintaining the latency state within HIV-1–infected cells. Overexpression of A3A in latently infected cell lines led to lower reactivation, while knockdown or knockout of A3A led to increased spontaneous and inducible HIV-1 reactivation. A3A maintains HIV-1 latency by associating with proviral DNA at the 5′ long terminal repeat region, recruiting KAP1 and HP1, and imposing repressive histone marks. We show that knockdown of A3A in latently infected human primary CD4 T cells enhanced HIV-1 reactivation. Collectively, we provide evidence and a mechanism by which A3A reinforces HIV-1 latency in infected CD4 T cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author contributions: M.T., E.S., Y.-C.H., and A.I. designed research; M.T. and E.S. performed research; M.T., E.S., and Y.-C.H. contributed new reagents/analytic tools; M.T., E.S., and A.I. analyzed data; and M.T. and A.I. wrote the paper.
Contributed by Akiko Iwasaki, December 13, 2018 (sent for review November 12, 2018; reviewed by Jeremy Luban and Daniel B. Stetson)
Reviewers: J.L., University of Massachusetts Medical School; and D.B.S., University of Washington.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1819386116